PSTV - Plus Therapeutics Inc. (PSTV) Q4 2023 Earnings Call Transcript
2024-03-05 19:07:07 ET
Plus Therapeutics, Inc. (PSTV)
Q4 2023 Earnings Conference Call
March 05, 2024, 05:00 PM ET
Company Participants
Marc Hedrick - President and CEO
Andrew Sims - CFO
Norman LaFrance - CMO
Conference Call Participants
Justin Walsh - Jones Trading
Sean Lee - H.C. Wainwright
Edward Woo - Ascendiant Capital
Presentation
Operator
Good afternoon, ladies and gentlemen. Welcome to the Plus Therapeutics Fourth Quarter and Full Year 2023 Results Conference Call. [Operator Instructions] Please be advised that today's conference is being recorded.
Before we begin, we want to advise you that over the course of the call and question-and-answer session, forward-looking statements will be made regarding events, trends, business prospects and financial performance, which may affect Plus Therapeutics' future operating results and financial position. All such statements are subject to risks and uncertainties and including the risks and uncertainties described under the Risk Factors section included in Plus Therapeutics' annual report on Form 10-K and quarterly reports on Form 10-Q filed with the Securities and Exchange Commission from time to time.
Plus Therapeutics advises you to review these risk factors in considering such statements. Plus Therapeutics assumes no responsibility to update or revise any forward-looking statements to reflect events, trends or circumstances after the date they are made.
It is now my pleasure to turn the floor over to Dr. Marc Hedrick, Plus Therapeutics' President and Chief Executive Officer. Sir, you may begin.
Marc Hedrick
Thank you, Victor. Good afternoon, everyone, and thank you once again for taking the time to join us today as we provide an overview of recent business highlights and discuss our 2023 full year financial results. And right upfront, apologies for the hoarseness in my voice as I come back from the flu....
Plus Therapeutics, Inc. (PSTV) Q4 2023 Earnings Call Transcript